Skip to main content

Closed

ZLAB: Zai Lab Limited Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+49.6% / yr

Operating margin-53.5%

ROIC-26.0%

Financially safe

Stretched

Debt / equity0.35×

Interest coverage-42.8×

Current ratio2.40×

Zai Lab Limited

ZLABNASDAQ Global Market·USD·Closed

Zai Lab Limited

ZLABNASDAQ·USD·Closed

$18.27

+0.33%

$18.27

+$0.06 (0.33%)

52W Range

10thpctl

Volume

0.40×avg

Mkt Cap

2.06BUSD

P/E

-11.1TTM

Div Yield

–ann

52W Range

10thpctl

Volume

0.40×avg

Market Cap

2.06BUSD

P/E Ratio

-11.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings